Nivolumab
CA045-009
Phase 3 mab completed
Quick answer
Nivolumab for Bladder Cancer is a Phase 3 program (mab) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Bladder Cancer
- Phase
- Phase 3
- Modality
- mab
- Status
- completed